A comprehensive view of Pediatrics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Abbott Laboratories Seeks Patent for Methods of Evaluating Brain Injury in a Pediatric Subject

INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT"

Regeneron’s Eylea injectable granted pediatric exclusivity by FDA for six months through May 17, 2024; Eylea treats wet age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy

Fennec Pharmaceuticals launches Pedmark sodium thiosulfate injection in US; drug reduces risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors

Decibel Therapeutics initiates Phase 1-2 clinical trial of DB-OTO gene therapy developed with Regeneron intended to provide hearing to patients with congenital hearing loss due to otoferlin deficiency; trial to involve pediatric patients

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count